
Dive Into Dollar Tr...


| Price and Volume | |
|---|---|
| Recent Price | 2.89 |
| 52 Week High | 5.86 |
| 52 Week Low | 2.34 |
| Avg. Daily Vol. (Mil) | 0.32 |
| Beta (3 year) | 0.66 |
| Share Related Items | |
| Mkt Cap (Mil) | 131.01 |
| Shares Out (Mil) | 45.33 |
| Float (Mil) | 37.92 |
| Dividend Information | |
| Yield % | 0.00 |
| Annual Dividend | 0.00 |
| Payout Ratio | 0.00 |
| Financial Strength | |
| Quick Ratio | 5.60 |
| Current Ratio | 5.60 |
| LT Debt/ Equity | 0.00 |
| Total Debt / Equity | 0.00 |
| Valuation Ratios | |
| Price Earnings | n.a. |
| Price/Sales | 13.27 |
| Price/Book | 9.77 |
| Price/Cash Flow | -34.50 |
| Per Share Data | |
| Earnings | -0.08 |
| Sales | 0.22 |
| Book Value | 0.30 |
| Cash Flow | -0.08 |
| Business Summary | |
|---|---|
| Pain Therapeutics, Inc., is a biopharmaceutical company that develops novel drugs. It has four drug candidates in clinical programs, including Remoxy, Oxytrex, PTI-202 and a novel radio-labeled monoclonal antibody to treat metastatic melanoma. | |
| General Information | |
| 7801 N. Capital of Texas Hig
Suite 260 Austin, TX 78731 |
|
| www.paintrials.com | |
| Industry : Drugs | |
| Sector: Health Care | |
| Employees: 8 | |
| CEO: Remi Barbier | |
| Short Interest | |
| Current Month (Mil) | 1.34 |
| Previous Month (Mil) | 1.21 |
| Short Interest Ratio (Days) | 5.40 |
| Management Effectiveness | |
| Return on Equity | n.a. |
| Return on Assets | -7.10 |
| Return on Investments | -28.00 |
| Profitability | |
| Gross Margin | n.a. |
| EBIT Margin | -40.20 |
| Profit Margin | -39.30 |